Patients details
| Disease (cases) | Number (case/eye) | Age (mean±SD) | Gender (M:F) |
| D-S | |||
| Skin biopsy: 16 | |||
| Lung biopsy: 15 | 46/61 | 67.0±8.6 | 6:40 |
| Clinical manifestation: 15 | |||
| S-S | 45/60 | 67.6±6.5 | 5:40 |
| Tumour/PIOL | |||
| DLBCL: 23 | |||
| T-LGL leukaemia: 2 | 27/34 | 67.4±14.5 | 13:14 |
| ATL: 1 | |||
| NK: 1 | |||
| Viral infection | |||
| VZV: 4 | |||
| HSV-1: 2 | |||
| HSV-2: 2 | 18/20 | 55.4±16.8* | 11:7 |
| CMV: 7 | |||
| HTLV-1: 3 | |||
| Non-sarcoidosis | |||
| Endophthalmitis: 10 | |||
| Behçet: 2 | 16/16 | 66.8±9.5 | 9:7 |
| Toxocara: 2 | |||
| Toxoplasma: 2 | |||
| Unknown | 39/43 | 61.6±2.9 | 14:25 |
| 191/234 | *V: D-S, V: S-S (p<0.05) | 47:118 |
All patients underwent vitreous analysis.
ATL, adult T-cell lymphoma; CMV, cytomegalovirus; DLBCL, diffuse large B-cell lymphoma; D-S, definitive sarcoidosis; HTLV-1, human T-cell leukemia virus; HSV, herpes simplex virus; NK, natural killer cell tumour; S-S, suspected sarcoidosis; PIOL, primary intraocular lymphoma; T-LGL, T-cell large granular lymphocyte leukemia; VZV, varicella zoster virus.